Emergent Biosolutions EBS Current ratio

Current ratio at other companies

Thermo Fisher ScientificTMO

1.6×-0.4×

Regeneron PharmaceuticalsREGN

3.3×-1.3×

SIGA TechnologiesSIGA

21.7×+11.6×

AMP

Amphastar PharmaceuticalsAMPH

2.4×-0.9×

Amneal Pharmaceuticals, Inc.AMRX

2.2×+0.8×

Lifecore Biomedical, Inc.LFCR

3.9×—

FAQ

What is Emergent Biosolutions's current ratio?

Emergent Biosolutions (EBS) reported current ratio of 5.4× in Q2 2026.

How has Emergent Biosolutions's current ratio changed year-over-year?

Emergent Biosolutions's current ratio decreased by 4.2% year-over-year, from 5.7× to 5.4×.

What is the long-term trend for Emergent Biosolutions's current ratio?

Over 5 years (2020 to 2025), Emergent Biosolutions's current ratio has grown at a 10.0% compound annual growth rate (CAGR), from 3.1× to 5×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.